Skip to main
GLMD
GLMD logo

Galmed Pharmaceuticals (GLMD) Market Capitalization Overview

Market Cap: $4.09M as of Jul 2, 2025

$4.09M
Past Month+$812.90K (24.83%)
As of Jul 2, 2025, Galmed Pharmaceuticals (GLMD) has a market capitalization of $4.09M. Over the past 30 days, its market cap has increased by 22.76%, while in the last 12 months, it has decreased by -22.68%.

Market capitalization represents the total value of Galmed Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Galmed Pharmaceuticals (GLMD) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Galmed Pharmaceuticals (GLMD) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Galmed Pharmaceuticals (GLMD) Market Cap History

DateMarket CapChange
Jul 1, 2025$4.02M+22.76%
Jun 2, 2025$3.28M+13.28%
May 1, 2025$2.90M+22.84%
Apr 1, 2025$2.36M-26.81%
Mar 3, 2025$3.22M-28.15%
Feb 3, 2025$4.48M-18.67%
Jan 2, 2025$5.51M+12.92%

Galmed Pharmaceuticals (GLMD) End of Year Market Cap History

DateMarket CapChange
2025$4.09M-22.68%
2024$5.29M+189.93%
2023$1.83M-85.53%
2022$12.61M-72.40%
2021$45.67M-31.15%
2020$66.33M

FAQs About Galmed Pharmaceuticals (GLMD) Market Cap

As of Jul 2, 2025, the market capitalization of Galmed Pharmaceuticals (GLMD) is $4.09M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Galmed Pharmaceuticals’s market capitalization has increased by 24.83%, changing from $3.28M to $4.09M as of Jul 2, 2025.

In the last 3 months, Galmed Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Galmed Pharmaceuticals’s market capitalization increased from $1.83M in January to $5.29M in December, reflecting a 189.93% change.

In the past five years, Galmed Pharmaceuticals (GLMD) has had a compound annual growth rate (CAGR) of -39.70% in market capitalization. This means its market cap has shrunk at an average rate of -39.70% per year.

Galmed Pharmaceuticals (GLMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.